Rafferty Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $638K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $1.45M | Sell |
|
|||||
|
2023
Q1 | $1.56M | Buy |
|
|||||
|
2022
Q4 | $1.04M | Buy |
|
|||||
|
2022
Q3 | $1.35M | Buy |
|
|||||
|
2022
Q2 | $925K | Sell |
|
|||||
|
2022
Q1 | $1.95M | Buy |
|
|||||
|
2021
Q4 | $2.04M | Buy |
|
|||||
|
2021
Q3 | $1.4M | Buy |
|
|||||
|
2021
Q2 | $1.57M | Sell |
|
|||||
|
2021
Q1 | $1.52M | Buy |
|
|||||
|
2020
Q4 | $307K | Sell |
|
|||||
|
2020
Q3 | $632K | Buy |
|
|||||
|
2020
Q2 | $401K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $867K | Sell |
|
|||||
|
2019
Q3 | $1.85M | Sell |
|
|||||
|
2019
Q2 | $2.05M | Sell |
|
|||||
|
2019
Q1 | $3.03M | Buy |
|